Marco Salvetti

Sapienza University of Rome - Department of Neuroscience, Mental Health and Sensory Organs, Center for Experimental Neurological Therapies (CENTERS)

Rome

Italy

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 29,526

SSRN RANKINGS

Top 29,526

in Total Papers Downloads

2,039

SSRN CITATIONS

1

CROSSREF CITATIONS

1

Scholarly Papers (3)

1.

Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis

Number of pages: 32 Posted: 08 Jul 2020
Department of Health Sciences (DISSAL), Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Department of Health Sciences, University of Genova, Department of Health Sciences, University of Genova, Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Department of Neurology, Multiple Sclerosis Center, IRCCS Ospedale San Raffaele, Department of Neurology and Multiple Sclerosis Center, ASST “Papa Giovanni XXIII, Multiple Sclerosis Center, Ospedale Guglielmo da Saliceto, Regional Referral Multiple Sclerosis Centre, Dept. of Neurology, University Hospital San Luigi, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Research Department, Italian Multiple Sclerosis Foundation, University of Campania “Luigi Vanvitelli” - First Division of Neurology, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Research Department, Italian Multiple Sclerosis Foundation, Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Sapienza University of Rome - Department of Neuroscience, Mental Health and Sensory Organs, Center for Experimental Neurological Therapies (CENTERS) and affiliation not provided to SSRN
Downloads 2,001 (9,524)
Citation 12

Abstract:

Loading...

Multiple Sclerosis; coronavirus; Immunomodulatory therapies; Immunosuppressive therapies

2.

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

Number of pages: 22 Posted: 23 Jul 2021
University of Genova - Section of Biostatistics, University of Genova - Department of Health Sciences, University of Genova - Section of Biostatistics, Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Università Vita-Salute San Raffaele, ASST Papa Giovanni XXIII - Department of Neurology and Multiple Sclerosis Center, Ospedale Guglielmo da Saliceto - Multiple Sclerosis Center, San Luigi Gonzaga University Hospital, ASST-Spedali Civili of Brescia, AISM Rehabilitation Center, Universita di Cagliari, IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB), City of Health and Science University Hospital of Turin - Department of Neuroscience - MS Center, Centro SM UOC Neurologia, Fidenza, AUSL PR, University of Pavia, Fondazione IRCCS Istituto Neurologico ‘Carlo Besta’, University of Rome Tor Vergata, University of Padua, IRCCS Ospedale Policlinico San Martino, University of Bari, University of Naples Federico II, University of Campania Federico II, Università Vita-Salute San Raffaele, University of Siena - Department of Life Sciences, University of Catania, Sapienza University of Rome - Department of Neuroscience, Mental Health and Sensory Organs, Center for Experimental Neurological Therapies (CENTERS) and Independent
Downloads 19 (648,678)

Abstract:

Loading...

Multiple Sclerosis, Coronavirus, Immunomodulatory therapies

3.

Effect of SARS-CoV-2 mRNA Vaccination in MS Patients Treated With Disease Modifying Therapies

Number of pages: 21 Posted: 20 Jul 2021
University of Genova - Section of Biostatistics, IRCCS Ospedale Policlinico San Martino, University of Genova - Department of Health Sciences, University of Genova - Section of Biostatistics, University of Genoa - Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), IRCCS Ospedale Policlinico San Martino, IRCCS Ospedale Policlinico San Martino - Laboratory Medicine, Imperia Hospital - Department of Neurology, Galliera Hospital - Neurology Unit, Ospedale Santa Corona Pietra Ligure (Sv) - S.C. Neurologia, SC Neurologia ASL 4 Chiavarese, AISM Rehabilitation Center, Centro Sclerosi Multipla S.C. Neurologia Asl 3 Genovese, Sant’Andrea Hospital - Department of Neurology, Università degli Studi di Siena - Clinica Neurologica e Malattie Neurometaboliche, Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Tor Vergata University and Hospital - Multiple Sclerosis Clinical and Research Unit, Università di Torino - Dipartimento di Scienze Cliniche e Biologiche, Università della Campania Luigi Vanvitelli - Centro Sclerosi Multipla, Università di Cagliari - Centro Sclerosi Multipla Ospedale Binaghi Cagliari - ATS Sardegna, ASST Crema - Neuroimmunology, Regina Montis Regalis Hospital - Department of Neurology, University of Pisa - Neurology Unit, University of Siena - Department of Medicine, Surgery and Neuroscience, Fabrizio Spaziani Hospital - Multiple Sclerosis Center, UOC Neurologia e Centro SM Fondazione Istituto G. Giglio, Università Federico II di Napopi - Clinica Neurologica, IRCCS Humanitas Research Hospital - Neuromuscular and Neuroimmunology Service, F. Tappeiner Hospital Meran (BZ) - MS Center, Careggi University Hospital - Department of Neurology 2, Ospedale Regionale - Department of Neurology, University of Siena - Department of Life Sciences, Sapienza University of Rome - Department of Neuroscience, Mental Health and Sensory Organs, Center for Experimental Neurological Therapies (CENTERS), IRCCS Ospedale Policlinico San Martino - Autoimmunology Laboratory, Università degli Studi di Genova - Center of Excellence for Biomedical Research (CEBR) and affiliation not provided to SSRN
Downloads 19 (663,168)

Abstract:

Loading...

multiple Sclerosis, Coronavirus, Immunomodulatory therapies